KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Receivables (2016 - 2018)

Evolent Health (EVH) has 4 years of Change in Receivables data on record, last reported at -$9.9 million in Q3 2018.

  • For Q3 2018, Change in Receivables fell 5627.91% year-over-year to -$9.9 million; the TTM value through Sep 2018 reached $17.4 million, up 20.05%, while the annual FY2017 figure was $11.3 million, 1.94% up from the prior year.
  • Change in Receivables reached -$9.9 million in Q3 2018 per EVH's latest filing, down from $4.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $16.9 million in Q1 2018 and bottomed at -$10.2 million in Q2 2015.
  • Average Change in Receivables over 4 years is $1.6 million, with a median of $4.1 million recorded in 2017.
  • The widest YoY moves for Change in Receivables: up 323.11% in 2018, down 5627.91% in 2018.
  • A 4-year view of Change in Receivables shows it stood at -$8.1 million in 2015, then soared by 216.63% to $9.4 million in 2016, then tumbled by 34.5% to $6.2 million in 2017, then plummeted by 259.34% to -$9.9 million in 2018.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$9.9 million in Q3 2018, $4.2 million in Q2 2018, and $16.9 million in Q1 2018.